Stable integration of a functional shRNA expression cassette into the murine leukemia virus genome

Virology

Volumn 351, Issue 1, 2006, Pages 218-225

  Sliva, Katja ^a,b   Schnierle, Barbara S ^b  

^a Institute for Biomedical Research   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

MLV; Replication; RNAi; shRNA

Indexed keywords

SHORT HAIRPIN RNA;

ANIMAL CELL; ARTICLE; CANCER GENETICS; CONTROLLED STUDY; GENE CASSETTE; GENE EXPRESSION; GENE FUNCTION; GENE INSERTION; GENE REPLICATION; GENE SILENCING; GENE TARGETING; GENE TRANSFER; GENETIC STABILITY; HUMAN; LENTIVIRINAE; LIFE CYCLE; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS GENOME;

ANIMALS; BASE SEQUENCE; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; RNA; RNA INTERFERENCE; VIRUS REPLICATION;

MURINE LEUKEMIA VIRUS;

EID: 33745906253     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.03.014     Document Type: Article

References (22)

1. Bennasser Y., Le S.Y., Benkirane M., and Jeang K.T. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22 (2005) 607-619
2. Bromberg-White J.L., Webb C.P., Patacsil V.S., Miranti C.K., Williams B.O., and Holmen S.L. Delivery of short hairpin RNA sequences by using a replication-competent avian retroviral vector. J. Virol. 78 (2004) 4914-4916
3. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
4. Bucher E., Hemmes H., de Haan P., Goldbach R., and Prins M. The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants. J. Gen. Virol. 85 (2004) 983-991
5. Couzin J. Breakthrough of the year. Small RNAs make big splash. Science 298 (2002) 2296-2297
6. Delgadillo M.O., Saenz P., Salvador B., Garcia J.A., and Simon-Mateo C. Human influenza virus NS1 protein enhances viral pathogenicity and acts as an RNA silencing suppressor in plants. J. Gen. Virol. 85 (2004) 993-999
7. Erlwein O., Buchholz C.J., and Schnierle B.S. The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virus. J. Gen. Virol. 84 (2003) 369-373
8. Kruse C.A., Roper M.D., Kleinschmidt-DeMasters B.K., Banuelos S.J., Smiley W.R., Robbins J.M., and Burrows F.J. Purified herpes simplex thymidine kinase Retrovector particles: I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors. Cancer Gene Ther. 4 (1997) 118-128
9. Lecellier C.H., Dunoyer P., Arar K., Lehmann-Che J., Eyquem S., Himber C., Saib A., and Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science 308 (2005) 557-560
10. Li W.X., Li H., Lu R., Li F., Dus M., Atkinson P., Brydon E.W., Johnson K.L., Garcia-Sastre A., Ball L.A., Palese P., and Ding S.W. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1350-1355
11. Logg C.R., Logg A., Tai C.K., Cannon P.M., and Kasahara N. Genomic stability of murine leukemia viruses containing insertions at the env-3′ untranslated region boundary. J. Virol. 75 (2001) 6989-6998
12. Lorimer I.A. Mutant epidermal growth factor receptors as targets for cancer therapy. Curr. Cancer Drug Targets 2 (2002) 91-102
13. Miyagishi M., and Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20 (2002) 497-500
14. Ram Z., Culver K.W., Oshiro E.M., Viola J.J., DeVroom H.L., Otto E., Long Z., Chiang Y., McGarrity G.J., Muul L.M., Katz D., Blaese R.M., and Oldfield E.H. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med. 3 (1997) 1354-1361
15. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Ihrig M.M., McManus M.T., Gertler F.B., Scott M.L., and Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
16. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory Press, Plainview, NY
17. Schnierle B.S., Moritz D., Jeschke M., and Groner B. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Ther. 3 (1996) 334-342
18. Sliva K., Erlwein O., Bittner A., and Schnierle B.S. Murine leukemia virus (MLV) replication monitored with fluorescent proteins. J. Virol. 1 (2004) 14
19. Tijsterman M., Ketting R.F., and Plasterk R.H. The genetics of RNA silencing. Annu. Rev. Genet. 36 (2002) 489-519
20. Vile R.G., Russell S.J., and Lemoine N.R. Cancer gene therapy: hard lessons and new courses. Gene Ther. 7 (2000) 2-8
21. Wikstrand C.J., Reist C.J., Archer G.E., Zalutsky M.R., and Bigner D.D. The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target. J. Neurovirol. 4 (1998) 148-158
22. Wikstrand C.J., Cokgor I., Sampson J.H., and Bigner D.D. Monoclonal antibody therapy of human gliomas: current status and future approaches. Cancer Metastasis Rev. 18 (1999) 451-464